Differentiation, differentiation/gene therapy and cancer
Identifieur interne : 000218 ( Istex/Corpus ); précédent : 000217; suivant : 000219Differentiation, differentiation/gene therapy and cancer
Auteurs : Robert E. ScottSource :
- Pharmacology and Therapeutics [ 0163-7258 ] ; 1996.
Abstract
“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.
Url:
DOI: 10.1016/S0163-7258(96)00120-9
Links to Exploration step
ISTEX:A872E25F8A0016161D9C07B67A70615355281714Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Differentiation, differentiation/gene therapy and cancer</title><author><name sortKey="Scott, Robert E" sort="Scott, Robert E" uniqKey="Scott R" first="Robert E." last="Scott">Robert E. Scott</name><affiliation><mods:affiliation>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A872E25F8A0016161D9C07B67A70615355281714</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/S0163-7258(96)00120-9</idno><idno type="url">https://api.istex.fr/document/A872E25F8A0016161D9C07B67A70615355281714/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000218</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000218</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Differentiation, differentiation/gene therapy and cancer</title><author><name sortKey="Scott, Robert E" sort="Scott, Robert E" uniqKey="Scott R" first="Robert E." last="Scott">Robert E. Scott</name><affiliation><mods:affiliation>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Pharmacology and Therapeutics</title><title level="j" type="abbrev">JPT</title><idno type="ISSN">0163-7258</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996">1996</date><biblScope unit="volume">73</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="51">51</biblScope><biblScope unit="page" to="65">65</biblScope></imprint><idno type="ISSN">0163-7258</idno></series><idno type="istex">A872E25F8A0016161D9C07B67A70615355281714</idno><idno type="DOI">10.1016/S0163-7258(96)00120-9</idno><idno type="PII">S0163-7258(96)00120-9</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0163-7258</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Robert E. Scott</name><affiliations><json:string>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Multistep differentiation process</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>proliferation control</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>AP1</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>SV40-T antigen and carcinogenesis</value></json:item></subject><language><json:string>eng</json:string></language><originalGenre><json:string>Review article</json:string></originalGenre><abstract>“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.</abstract><qualityIndicators><score>6.116</score><pdfVersion>1.2</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>4</keywordCount><abstractCharCount>652</abstractCharCount><pdfWordCount>8619</pdfWordCount><pdfCharCount>65005</pdfCharCount><pdfPageCount>15</pdfPageCount><abstractWordCount>93</abstractWordCount></qualityIndicators><title>Differentiation, differentiation/gene therapy and cancer</title><pii><json:string>S0163-7258(96)00120-9</json:string></pii><genre><json:string>review-article</json:string></genre><serie><volume>68</volume><pages><last>382</last><first>378</first></pages><language><json:string>unknown</json:string></language><title>Proc. Natl. Acad. Sci. USA</title></serie><host><volume>73</volume><pii><json:string>S0163-7258(00)X0024-1</json:string></pii><pages><last>65</last><first>51</first></pages><issn><json:string>0163-7258</json:string></issn><issue>1</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><title>Pharmacology and Therapeutics</title><publicationDate>1997</publicationDate></host><categories><wos><json:string>science</json:string><json:string>pharmacology & pharmacy</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>pharmacology & pharmacy</json:string></scienceMetrix></categories><publicationDate>1996</publicationDate><copyrightDate>1996</copyrightDate><doi><json:string>10.1016/S0163-7258(96)00120-9</json:string></doi><id>A872E25F8A0016161D9C07B67A70615355281714</id><score>0.1875791</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/A872E25F8A0016161D9C07B67A70615355281714/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/A872E25F8A0016161D9C07B67A70615355281714/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A872E25F8A0016161D9C07B67A70615355281714/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Differentiation, differentiation/gene therapy and cancer</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1996</date></publicationStmt><notesStmt><note>Associate Editor: E. Huberman</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Differentiation, differentiation/gene therapy and cancer</title><author xml:id="author-1"><persName><forename type="first">Robert E.</forename><surname>Scott</surname></persName><affiliation>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</affiliation></author></analytic><monogr><title level="j">Pharmacology and Therapeutics</title><title level="j" type="abbrev">JPT</title><idno type="pISSN">0163-7258</idno><idno type="PII">S0163-7258(00)X0024-1</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996"></date><biblScope unit="volume">73</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="51">51</biblScope><biblScope unit="page" to="65">65</biblScope></imprint></monogr><idno type="istex">A872E25F8A0016161D9C07B67A70615355281714</idno><idno type="DOI">10.1016/S0163-7258(96)00120-9</idno><idno type="PII">S0163-7258(96)00120-9</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1996</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.</p></abstract><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Multistep differentiation process</term></item><item><term>proliferation control</term></item><item><term>AP1</term></item><item><term>SV40-T antigen and carcinogenesis</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1996">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/A872E25F8A0016161D9C07B67A70615355281714/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="rev"><item-info><jid>JPT</jid><aid>96001209</aid><ce:pii>S0163-7258(96)00120-9</ce:pii><ce:doi>10.1016/S0163-7258(96)00120-9</ce:doi><ce:copyright type="unknown" year="1996"></ce:copyright></item-info><head><ce:title>Differentiation, differentiation/gene therapy and cancer</ce:title><ce:author-group><ce:author><ce:given-name>Robert E.</ce:given-name><ce:surname>Scott</ce:surname></ce:author><ce:affiliation><ce:textfn>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</ce:textfn></ce:affiliation></ce:author-group><ce:miscellaneous>Associate Editor: E. Huberman</ce:miscellaneous><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation <ce:italic>in vitro</ce:italic> as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Multistep differentiation process</ce:text></ce:keyword><ce:keyword><ce:text>proliferation control</ce:text></ce:keyword><ce:keyword><ce:text>AP1</ce:text></ce:keyword><ce:keyword><ce:text>SV40-T antigen and carcinogenesis</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Differentiation, differentiation/gene therapy and cancer</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Differentiation, differentiation/gene therapy and cancer</title></titleInfo><name type="personal"><namePart type="given">Robert E.</namePart><namePart type="family">Scott</namePart><affiliation>Department Of Pathology, The University Of Tennessee Medical Center, 800 Madison Avenue, Memphis TN 38163, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="Review article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1996</dateIssued><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">“Differentiation, Differentiation/Gene Therapy and Cancer” is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/ gene therapy.</abstract><note>Associate Editor: E. Huberman</note><subject><genre>Keywords</genre><topic>Multistep differentiation process</topic><topic>proliferation control</topic><topic>AP1</topic><topic>SV40-T antigen and carcinogenesis</topic></subject><relatedItem type="host"><titleInfo><title>Pharmacology and Therapeutics</title></titleInfo><titleInfo type="abbreviated"><title>JPT</title></titleInfo><genre type="journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">1997</dateIssued></originInfo><identifier type="ISSN">0163-7258</identifier><identifier type="PII">S0163-7258(00)X0024-1</identifier><part><date>1997</date><detail type="volume"><number>73</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="issue pages"><start>1</start><end>74</end></extent><extent unit="pages"><start>51</start><end>65</end></extent></part></relatedItem><identifier type="istex">A872E25F8A0016161D9C07B67A70615355281714</identifier><identifier type="DOI">10.1016/S0163-7258(96)00120-9</identifier><identifier type="PII">S0163-7258(96)00120-9</identifier><recordInfo><recordContentSource>ELSEVIER</recordContentSource></recordInfo></mods></metadata></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000218 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000218 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= DanceTherParkinsonV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A872E25F8A0016161D9C07B67A70615355281714
|texte= Differentiation, differentiation/gene therapy and cancer
}}
| This area was generated with Dilib version V0.6.35. |  |